Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Jul 18, 2014

NEW YORK (GenomeWeb) – RainDance Technologies said this week that it has appointed Kathy Ordoñez to its board of directors.

Ordoñez has more than 30 years of experience in the life sciences and diagnostics industries. She previously served as senior vice president at Quest Diagnostics, which she joined following Quest's acquisition of Celera in 2011. Prior to the acquisition, Ordoñez was CEO at Celera and a founder of Celera Diagnostics. Earlier in her career, Ordoñez held several senior positions at Hoffmann La-Roche, overseeing the formation of Roche Molecular Systems, where she served as president and CEO.


Illumina has hired Tina Nova to be senior vice president and general manager of the firm's oncology business. Rick Klausner has been serving as interim oncology leader since January and will continue in his role as senior vice president and chief medical officer.

Nova was cofounder of molecular diagnostics company Genoptix and served as its president and CEO from 2000 until the firm was acquired by Novartis in 2011. She also cofounded Nanogen, a provider of MDx tests, and served as its COO and president from 1994 until 2000.


WaferGen Biosystems' board of directors has appointed President and CEO Ivan Trifunovich to the additional post of chairman of the board. He replaces Alnoor Shivji, who has been chairman since 2002 and has resigned to focus on a new startup venture. WaferGen said Joel Kanter, who has been a director since 2007, will serve as lead independent director.


MolecularHealth has hired Gabriel Bien-Willner as medical director of its CLIA-certified next-generation sequencing laboratory in The Woodlands, Texas. Bien-Willner will report to Chief Medical Officer Shelly Gunn and manage the day-to-day clinical duties of the laboratory. He has dual-board certifications in anatomic pathology and molecular genetic pathology. Previously, he served as a faculty member in the department of pathology and immunology at Washington University in St. Louis, where he conducted research in cancer biomarker discovery and the development of novel genomic technologies.


David Snyder has resigned from his posts as executive VP and chief financial officer at Cellular Dynamics International, and Timothy Daley has joined the firm as VP and interim chief financial officer.

Daley will take over Snyder's roles as the company's principal financial and accounting officer. Daley has been a consultant for Cellular Dynamics since 2009, and he provided CFO/controller and SEC reporting services to several organizations through his consulting firm.


The American Society of Human Genetics has named David Valle the recipient of its annual Victor A. McKusick Leadership award, which recognizes individuals who enrich the development of human genetics, and its assimilation into science, medicine, and health.

Valle is a professor and director of the McKusick-Nathans Institute of Genetic Medicine at the Johns Hopkins University School of Medicine. His research has focused on genetic factors involved in human health and disease, and he has characterized the molecular basis of many single-gene disorders, developed mouse models for studying disease, and analyzed genetic variants associated with psychiatric illnesses.



Promoted? Changing jobs? GenomeWeb wants to know. [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.
The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.